PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus

Emerging Infectious Diseases

Volumn 20, Issue 5, 2014, Pages 847-849

  Wang, Wei ^a   Song, Zhigang ^a   Guan, Wencai ^a   Liu, Yi ^a   Zhang, Xiaonan ^a   Xu, Lei ^a   Li, Jianhua ^a   Yuan, Zhenghong ^a   Hu, Yunwen ^a  

^a SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE; ANTIVIRUS AGENT; NA PROTEIN, INFLUENZA A VIRUS; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS; GENE SEQUENCE; HUMAN; HUMAN RHINOVIRUS; IMMUNE RESPONSE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H7N9; INFLUENZA VIRUS B; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM ANALYSIS; VIRUS LOAD; ANTIVIRAL RESISTANCE; DRUG EFFECTS; GENETICS; INFLUENZA, HUMAN; MUTATION; POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MUTATION; NEURAMINIDASE; OSELTAMIVIR; POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 84898910612     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2005.131364     Document Type: Article

References (7)

1. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888-97. http://dx.doi.org/10.1056/NEJMoa1304459
2. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277-85. http://dx.doi.org/10.1056/ NEJMoa1305584
3. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013;381:2273-9. http://dx.doi. org/10.1016/S0140-6736(13)61125-3
4. Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV. R292K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerg Infect Dis. 2013;19:1521-4. http://dx.doi.org/ 10.3201/eid1909.130724
5. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013;501:551-5. http://dx.doi.org/10.1038/nature12392
6. Liu CM, Driebe EM, Schupp J, Kelley E, Nguyen JT, McSharry JJ, et al. Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis. J Virol Methods. 2010;163:109-15. http://dx.doi.org/10.1016/ j.jviromet.2009.09.007
7. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol. 2010;84:12069-74. http://dx.doi. org/10.1128/JVI.01639-10